2018 saw a female mortality from cvd, cancer, diabetes or crd between exact ages 30 and 70 of 13.5% in Mexico, a decrease of 0.1% (-0.7%).
Female mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 in Mexico
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2019
Points:
13,760
Measure:
%
Similar regions to Mexico
Female CVD, cancer, diabetes or CRD
More indicators for Mexico
Out-of-pocket expenditure PPP per capita
intl dollar492
+intl dollar46
(2021)
Newborns protected against tetanus
98%
0%
(2022)
Female wasting in children
0.6%
-1.1%
(2022)
Birth registration
97%
+2%
(2020)
Female prevalence of HIV
0.1%
0%
(2022)
Contraceptive modern method prevalence
69.8%
+4.8%
(2018)
Mexico Female CVD, cancer, diabetes or CRD between 2000 and 2019
| Period | Female CVD, cancer, diabetes or CRD | Change |
|---|---|---|
| 2019 | 13.5% | -0.1% |
| 2018 | 13.6% | -0.1% |
| 2017 | 13.7% | -0.3% |
| 2016 | 14% | +0.1% |
| 2015 | 13.9% | +0.1% |
| 2014 | 13.8% | +0.3% |
| 2013 | 13.5% | -0.4% |
| 2012 | 13.9% | 0% |
| 2011 | 13.9% | -0.6% |
| 2010 | 14.5% | -0.2% |
| 2009 | 14.7% | -0.3% |
| 2008 | 15% | +0.2% |
| 2007 | 14.8% | -0.5% |
| 2006 | 15.3% | -0.4% |
| 2005 | 15.7% | 0% |
| 2004 | 15.7% | -0.4% |
| 2003 | 16.1% | +0.1% |
| 2002 | 16% | +0.3% |
| 2001 | 15.7% | -0.3% |
| 2000 | 16% |